395 related articles for article (PubMed ID: 21076071)
1. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
[TBL] [Abstract][Full Text] [Related]
2. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
3. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
4. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
[TBL] [Abstract][Full Text] [Related]
6. Role of different pathways of the complement cascade in experimental bullous pemphigoid.
Nelson KC; Zhao M; Schroeder PR; Li N; Wetsel RA; Diaz LA; Liu Z
J Clin Invest; 2006 Nov; 116(11):2892-900. PubMed ID: 17024247
[TBL] [Abstract][Full Text] [Related]
7. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
[TBL] [Abstract][Full Text] [Related]
8. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
[TBL] [Abstract][Full Text] [Related]
9. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
[TBL] [Abstract][Full Text] [Related]
11. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation.
Chen R; Fairley JA; Zhao ML; Giudice GJ; Zillikens D; Diaz LA; Liu Z
J Immunol; 2002 Oct; 169(7):3987-92. PubMed ID: 12244200
[TBL] [Abstract][Full Text] [Related]
12. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.
Sesarman A; Mihai S; Chiriac MT; Olaru F; Sitaru AG; Thurman JM; Zillikens D; Sitaru C
Br J Dermatol; 2008 Mar; 158(3):463-71. PubMed ID: 18205879
[TBL] [Abstract][Full Text] [Related]
13. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
[TBL] [Abstract][Full Text] [Related]
14. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
Dainichi T; Chow Z; Kabashima K
J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
[TBL] [Abstract][Full Text] [Related]
15. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
[TBL] [Abstract][Full Text] [Related]
16. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
19. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.
Chen R; Ning G; Zhao ML; Fleming MG; Diaz LA; Werb Z; Liu Z
J Clin Invest; 2001 Oct; 108(8):1151-8. PubMed ID: 11602622
[TBL] [Abstract][Full Text] [Related]
20. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
Toosi S; Bystryn JC
Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
